Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 102638
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.102638
Table 1 Baseline data of 280 patients with colorectal cancer, n (%)
Characteristics

Ca2+-first postoperative day
P value
High group (> 1.975 mmol/L)
Low group (< 1.975 mmol/L)
n179101
Ethnic group0.821
Han ethnic group149 (83.2)83 (82.2)
Others30 (16.8)18 (17.8)
Sex0.693
Female77 (43.0)41 (40.6)
Male102 (57.0)60 (69.4)
Age (years)0.012a
< 65121 (67.6)53 (52.5)
≥ 6558 (32.4)48 (47.5)
BMI0.383
< 23.565 (36.3)42 (41.6)
≥ 23.5114 (63.7)59 (58.4)
Tumor location0.709
Right half of colon37 (22.6)19 (15.1)
Left half of colon142 (77.4)82 (84.9)
Degree of differentiation0.018a
High differentiation24 (13.4)3 (3.0)
Moderately differentiated127 (70.9)80 (79.2)
Poorly differentiated28 (15.6)18 (17.8)
T stage0.313
T1-239 (21.8)21 (20.8)
T3106 (59.2)53 (52.5)
T434 (19.0)27 (26.7)
N stage0.907
0102 (54.7)55 (52.3)
N148 (45.3)28 (47.7)
N229 (16.2)18 (17.8)
Neurovascular invasion0.463
No133 (74.3)79 (78.2)
Yes46 (25.7)22 (21.8)
MSI0.698
MSS164 (91.6)94 (93.1)
MSI-H15 (8.4)7 (6.9)
CEA (ug/L)0.002a
< 5129 (72.1)54 (53.5)
≥ 550 (27.9)47 (46.5)
CA19-9 (U/mL)0.304
< 39158 (85.8)90 (90.7)
≥ 3921 (14.2)11 (9.3)
Hb (g/L)0.753
< 12050 (27.9)30 (29.7)
≥ 120129 (72.1)71 (70.3)
PLT (109/L)0.641
< 330143 (79.9)83 (82.2)
≥ 33036 (20.1)18 (17.8)
Alb (g/L)0.175
< 4065 (36.3)45 (44.6)
≥ 40114 (63.7)56 (55.4)
Ca2+-baseline (mmol/L)0.005a
< 2.1124 (7.5)11 (9.3)
≥ 2.11155 (92.5)90 (90.7)
δCa2+< 0.001a
< 0.245145 (81.0)28 (27.7)
≥ 0.24534 (19.0)73 (72.3)